A similar improvement in diagnostic accuracy was found for the comparison of patients with AD and patients with PDD, where the inclusion of p-tau, α-syn, and FABP3 led to an AUC of 0.96 with a specificity of 88% and a sensitivity of 100%. The gene discussed is FABP3; the disease is Alzheimer disease.